|
Reintroducing
Indian pharma
From US to Europe, Latin America to CIS and now Africa; Indian
pharmacos are on a world tour. But are they travelling so
far that they will uproot from India? Katya Naidu does a status
check
Flamingo
bags CRAMS order from Teva
Flamingo Pharmaceuticals, a quality-driven Indian pharmaceutical
company with an experience of over two decades in global pharmaceutical
markets announced that it has bagged the order from Teva Group
to manufacture Zolpidem tartrate tablets for Netherlands market.
USV's
facility secures USFDA approval
USV has recently announced that its solid formulations facility
at Daman has received USFDA approval. The company has filed
four ANDAs in the US through Indicus Pharma, its affiliate
company.
Shasun
signs licensing deal with Lundbeck
Shasun Chemicals & Drugs' wholly-owned UK-subsidiary Shasun
Pharma Solutions has entered into a non-exclusive licensing
agreement with H Lundbeck, a research based Danish company
engaged in finding new drugs for treatment of CNS (Central
Nervous System) disorders.
Glenmark
fuels its biologics pipeline
Glenmark has purchased two monoclonal antibodies from a Canadian
company Chromos Molecular Systems.
Alkem
forays into preventive care market
Alkem Laboratories has entered into a licensing agreement
with Cooper Surgicals, a business unit of the Cooper Companies,
for Medscanc cytobrushes for women's healthcare markets.
Elder
to market Enzymotec's CardiaBeat
Elder Pharmaceuticals has entered into an exclusive in-licensing
agreement with Enzymotec of Israel for launching CardiaBeat,
a cholesterol reducing dietary supplement in the Indian market.
Evotec,
RSIL to jointly provide compound libraries
Research Support International (RSIL) and Evotec have planned
a joint venture in India to form Evotec-RSIL. This company
will design, synthesise and manage compound libraries as a
service.
Alpa
enters capital markets with IPO
Alpa Laboratories Limited (ALL), a multi-product pharmaceuticals
formulations company, has entered the capital market with
a public issue of 95,00,000 equity shares of Rs 10 each for
cash at a premium to be decided through the 100 percent book
building process.
Biovel
launches operations in India
Biovel Life Sciences, an integrated biotechnology enterprise,
has recently announced commencement of its operations in India.
Granules
ties up with US company
Hyderabad-based pharmaceutical firm Granules India went in
for a strategic tie-up with Heritage Pharmaceuticals of USA.
Wockhardt
to launch anti-epileptic injection
Wockhardt received tentative approval from the USFDA for marketing
Fosphenytoin injections containing 50 mg Phenytoin equivalents.
'Sales
of an OTC product depends on the company'
While the Rx market is the on the growth path in India, the
OTC business is not lagging behind either. Hitesh Gajaria,
Chartered Accountant, KPMG talks to Katya Naidu about the
future of OTC in India.
Is
India 'somebody'?
"From nobody in 1977, we are somebody today," remarked
Dr Venkateswarulu, Drug Controller General of India, at ISPE
India's annual conference on 'Aseptic Manufacturing and Contamination
Controls—Current Issues and Trends’, in Mumbai.
I
Pharma
focus at India Packaging Show 2007
This year's India Packaging Show 2007 promises to be the largest
packaging event of the country, as it is being held together
with India Converting Show, India Flexo Show and India Corrugated
Show 2007.
|
